Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02052648
Title Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NewLink Genetics Corporation
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.